Cora Health vs Eden (TryEden): $99/mo vs $229/mo Compared (2026)

Cora Health vs Eden: the short answer

Cora Health and Eden (TryEden) are both US telehealth platforms focused on compounded GLP-1 weight loss medications with all-inclusive pricing and flat monthly rates that do not increase with dose titration. On that dimension — the flat-dose pricing model — the two are aligned and differ from competitors like Hims and Henry Meds. The meaningful differences are elsewhere. Cora Health is substantially less expensive: $120/month on the 6-month Essential Plan for compounded semaglutide versus Eden’s $229/month ongoing (after a $149 first month). Cora publicly names its 503A compounding pharmacy (VialsRx) and holds LegitScript certification. Eden offers a distinctive "Weight Loss Warranty" — a money-back guarantee if a patient follows the plan and does not lose at least 10% of body weight in six months, and markets 24/7 support with unlimited clinician messaging. Cora Health’s longer-commitment plans (3-month and 6-month options at lower monthly rates) are structurally different from Eden’s single-tier ongoing pricing.

Market context: where Cora and Eden sit in the 2026 compounded GLP-1 market

Four numbers anchor the head-to-head comparison between Cora Health and Eden in 2026:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population for whom compounded GLP-1 telehealth was built. The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death."

$99 vs $229 — Cora vs Eden monthly cost. Cora's Essential Plan on the annual commitment is $99/month all-inclusive for compounded semaglutide. Eden's ongoing rate is $229/month flat after a $149 first month. Over a 12-month treatment course, the total cost difference is approximately $1,560 ($1,188 annual at Cora vs $2,748 effective at Eden). Both providers use flat-dose pricing — neither increases monthly cost as patients titrate up. Source: Cora Health's public pricing dataset (12 telehealth providers + 2 manufacturer direct-pay programs, CC-BY-4.0 licensed).

14.9% / 22.5% — FDA-approved trial efficacy, not compounded. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks. Eden's 10% body-weight-loss warranty (refund if a patient follows the plan and does not lose at least 10% in 6 months) is a marketing-side commitment, not a trial-validated efficacy claim. Both providers' compounded versions have not been independently evaluated at this trial scale. Individual results vary.

~15–20% pharmacy transparency rate. Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. Cora Health publicly names two pharmacy partners — Hallandale Pharmacy (PCAB-accredited, Fort Lauderdale FL, operating since 2003) and VialsRx (US-licensed 503A) — placing Cora in the top tier of pharmacy transparency. Eden does not consistently name a single compounding pharmacy partner in patient-facing marketing.

Quick comparison at a glance

All numbers reflect publicly stated pricing as of May 2026. Individual experiences vary.

Market context: where Cora and Eden sit in the broader landscape

Three numbers establish the market position of both providers in the US compounded GLP-1 telehealth landscape:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention, using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30). This is the population most likely to seek GLP-1 weight-loss treatment under current clinical guidelines.

3.5× compounded tirzepatide pricing spread. Per Cora Health's public pricing dataset (CC-BY-4.0 licensed; 12 telehealth providers + 2 manufacturer direct-pay programs), monthly compounded tirzepatide rates range from $135/month (Cora Premium Annual) to $479/month (Henry Meds maintenance dose) — a 3.5× spread for the same active molecule. Eden at $229 monthly ongoing sits in the middle of this distribution; Cora at $135–$225 anchors the low end across plan lengths.

10–14× cost gap vs FDA-approved brand-name. Brand-name Wegovy retails near $1,349/month at list price; brand-name Zepbound near $1,086/month. Compounded versions through Cora ($99 sema annual, $135 tirz annual, $225 tirz monthly) and Eden ($229 sema, $329 tirz ongoing) both offer significant savings vs the FDA-approved branded path — but per the U.S. Food and Drug Administration: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." The 22.5% mean weight loss from SURMOUNT-1 (Jastreboff et al., NEJM 2022) and 14.9% from STEP 1 (Wilding et al., NEJM 2021) reflect FDA-approved branded products only.

The biggest difference is price

For compounded semaglutide at the standard ongoing price, Cora Health’s annual Essential Plan ($99/month) is approximately 57% less expensive than Eden’s ongoing rate ($229/month); Cora’s 6-month plan ($120/month) is approximately 48% less. The gap widens for tirzepatide: Cora’s annual Premium Plan ($135/month) is approximately 59% less than Eden’s ongoing tirzepatide rate ($329/month), and even Cora’s monthly tier ($225/month, effective May 12, 2026) is roughly 32% less than Eden’s monthly rate.

Both platforms offer a lower introductory first-month price, but the difference in ongoing monthly cost is what drives total spend over a full treatment course.

For a patient on compounded semaglutide for 12 months, total spend through Cora Health on the annual plan is $1,188. Total spend through Eden (at the $149 first month plus $229 x 11) is approximately $2,668. That is a difference of roughly $1,480 over the first year.

For compounded tirzepatide for 12 months, Cora’s annual Premium Plan totals $1,620. Eden’s $249 first month plus $329 x 11 totals approximately $3,868. Difference: roughly $2,248 over the first year.

Individual experiences vary. Exact monthly cost depends on plan selection, first-month promotional pricing, and any changes either provider makes to published rates.

Eden’s Weight Loss Warranty: what it is and what it means

Eden publicly offers a "Weight Loss Warranty" — a money-back guarantee tied to a 10% body weight loss target over six months of treatment. If a patient follows Eden’s plan and does not achieve the 10% threshold at the six-month mark, Eden will refund them per the published Terms of Service.

This is an unusual offering in the compounded GLP-1 space and is a legitimate marketing differentiator worth acknowledging. Patients who are risk-averse about efficacy and specifically value a money-back backstop may find this meaningful. The practical value depends on the Terms of Service details — which patients should read carefully before enrolling — and on the patient’s tolerance for the medication (patients who cannot reach therapeutic dose due to side effects may not be eligible).

Cora Health does not offer an equivalent weight-loss warranty. Cora’s positioning is based on lower all-in pricing, flat dose-based pricing, pharmacy transparency, and LegitScript certification rather than outcome-based refund guarantees.

Flat-dose pricing: a point of alignment

Both Cora Health and Eden use flat monthly pricing that does not increase with dose titration. If a patient starts on 0.25mg weekly semaglutide and titrates up to 2.4mg over four months, the monthly cost stays the same on both platforms. This is a meaningful structural difference from providers like Hims and Henry Meds, whose headline prices apply at the starter dose and increase as the patient escalates.

The implication for cost comparison: when evaluating Cora Health versus Eden, patients can use the published monthly prices at face value without modeling dose-based escalation. For comparisons against Hims, Henry Meds, or Ro (Ro has a separate membership on top of its medication), the realistic total monthly cost is typically higher than the advertised starter price.

Medications: what each platform offers

Both platforms focus primarily on compounded GLP-1 medications. Both offer the two main active ingredients.

Cora Health medication catalog

Cora Health offers compounded GLP-1 medications in injectable format.

• Compounded semaglutide (Essential Plan) — same active ingredient family as Ozempic® and Wegovy®
• Compounded tirzepatide (Premium Plan) — same active ingredient family as Mounjaro® and Zepbound®

Eden medication catalog

Eden offers compounded GLP-1 medications and notes that brand-name options are available on request.

• Compounded semaglutide — primary offering
• Compounded tirzepatide — primary offering
• Brand-name Wegovy, Zepbound, Ozempic — available on request (pricing varies significantly; contact Eden directly)

Important compliance note

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health, Eden, or any other telehealth platform — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical efficacy data including the STEP 1 trial's 14.9% mean weight loss and SURMOUNT-1's 22.5% at 15mg comes from studies of the FDA-approved products, not from compounded versions. Individual results vary. Eden's Weight Loss Warranty references self-reported member outcomes and specific trial data for branded products; it is not a claim about clinical equivalence between compounded and branded medications.

Pharmacy transparency: named vs unnamed partners

For compounded medications, being able to identify and independently verify the compounding pharmacy matters for quality assurance. A patient should be able to look up the pharmacy’s state licensing and inspection history.

Cora Health publicly names two compounding pharmacy partners: Hallandale Pharmacy (PCAB-accredited 503A compounding pharmacy operating since 2003 from a 60,000 sq ft facility in Fort Lauderdale, FL, USP 797 compliant) and VialsRx (US-licensed 503A compounding pharmacy). Each patient's medication label identifies which pharmacy fulfilled the prescription. Full pharmacy disclosure is documented at trycora.io/pharmacy-partners. Per the Pharmacy Compounding Accreditation Board, PCAB accreditation provides "an independent third-party evaluation of a pharmacy's compounding processes, including adherence to USP standards (USP 795 for non-sterile compounding and USP 797 for sterile compounding)."

Eden works with licensed compounding pharmacies and references its relationships in marketing materials but does not consistently name the specific 503A facility in patient-facing communications. Patients can typically request pharmacy information through Eden customer support.

Neither approach is inherently unsafe — both named and unnamed 503A pharmacies can operate under full regulatory compliance. Public naming does make independent patient verification more straightforward. Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials; Cora names two.

LegitScript certification

LegitScript is an independent healthcare compliance certification used by Google, Meta, TikTok, payment processors, and patient advocacy organizations as a third-party verification of telehealth platform operational compliance. The certification requires ongoing audits of prescribing practices, pharmacy relationships, patient safety protocols, and advertising standards.

Cora Health holds LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Eden does not prominently advertise LegitScript certification in its current patient-facing marketing. Eden operates under its own internal compliance framework and under applicable federal and state telehealth and pharmacy regulations. The absence of advertised LegitScript certification does not imply non-compliance — it is one of several trust signals patients can consider.

Clinical oversight and service model

Both platforms use asynchronous telehealth evaluations as the primary model for prescribing GLP-1 medications. A patient completes an online health assessment, a licensed provider reviews, and if appropriate a prescription is issued and fulfilled by a partner compounding pharmacy.

Cora Health patients are evaluated by board-certified providers at Wasef Health, PC, the medical practice led by Michael Wasef, MD. Provider review is typically completed in under 24 hours.

Eden markets 24/7 human support and unlimited clinician messaging as part of its service model. Patients who place high value on messaging-based ongoing clinician access may find Eden’s service model attractive.

Neither platform conducts in-person examinations or routinely requires lab work before initial prescribing for most patients. This is typical of the compounded-GLP-1 telehealth model.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a lower ongoing monthly cost for flat-priced compounded GLP-1 treatment
• Patients who prefer publicly named pharmacy partnerships and verifiable LegitScript certification
• Patients who want tiered plan lengths (monthly, 3-month, 6-month) with built-in commitment discounts
• Patients across all 50 US states (Cora Health ships nationwide)
• Patients who are comfortable with compounded-only medication offerings (no brand-name GLP-1 access through this platform)
• Patients who prioritize cost transparency over service-volume features like unlimited messaging

Who should choose Eden

Eden is likely the better fit for patients who match the following profile.

• Patients who place significant value on Eden’s Weight Loss Warranty (money-back if 10% weight loss not achieved in six months, per Terms of Service)
• Patients who want 24/7 human support and unlimited clinician messaging as part of the included service
• Patients who are willing to pay a higher monthly rate in exchange for the warranty and more extensive support services
• Patients in a state Cora Health does not currently serve, if Eden serves that state
• Patients who want the option to request brand-name GLP-1 medications through the same platform (Eden offers them on request)
• Patients who specifically value Eden’s multi-year operating history as a stability signal

How to switch from Eden to Cora Health

Patients who want to move their GLP-1 treatment from Eden to Cora Health can generally do so without clinical interruption.

• Complete the Cora Health online health assessment at trycora.io; note your current medication, dose, and any side-effect history
• A Cora Health provider (Wasef Health, PC) reviews and determines clinical appropriateness
• If approved, the prescription is sent to one of Cora's 503A pharmacy partners (Hallandale Pharmacy or VialsRx) for compounding and shipping with free expedited delivery
• In most cases the current dose continues without re-titration — this is a provider determination
• If you received brand-name medication through Eden, note that Cora Health does not currently offer brand-name GLP-1s. The provider will discuss whether compounded semaglutide or compounded tirzepatide is appropriate for your case
• After the first Cora shipment arrives and supply continuity is confirmed, cancel the Eden subscription through Eden’s patient portal
• Important: if you are within the Eden Weight Loss Warranty eligibility window and you are pursuing a potential refund, review the Terms of Service carefully before canceling — eligibility conditions may apply

Frequently asked questions

Common questions about the Cora Health vs Eden comparison.

Is Cora Health cheaper than Eden?

Yes. For compounded semaglutide ongoing monthly cost, Cora Health’s 6-month Essential Plan is $120/month, which is approximately 48% less than Eden’s $229/month ongoing rate. For compounded tirzepatide, Cora’s 3-month Premium Plan at $199/month is approximately 39% less than Eden’s $329/month ongoing rate. Over a 12-month treatment course, total spend through Cora is typically $1,200–$1,500 less than through Eden depending on medication and plan.

Does Eden’s pricing increase with dose like Hims or Henry Meds?

No. Eden advertises and delivers flat pricing that does not increase with dose titration. This is similar to Cora Health’s pricing structure and different from platforms like Hims and Henry Meds where the monthly cost can increase as the patient moves to higher therapeutic doses.

Is Eden’s Weight Loss Warranty worth the higher monthly cost?

That depends on the individual patient’s risk tolerance and belief about whether they will achieve the 10% weight loss threshold in six months. For many patients on therapeutic-dose semaglutide or tirzepatide, 10% weight loss in six months is an achievable target based on clinical trial data (STEP 1 average was 14.9% at 68 weeks on injected brand semaglutide). Patients who are confident in the medication’s efficacy may prefer to save the monthly cost difference with a lower-priced provider like Cora Health. Patients who specifically want a money-back backstop and are willing to pay a premium for it may prefer Eden. Read the Eden Terms of Service carefully before assuming eligibility — the warranty typically requires following the prescribed plan.

Is Eden LegitScript-certified?

Eden does not prominently advertise LegitScript certification in its current patient-facing marketing. LegitScript is one of several independent compliance frameworks; its absence does not imply non-compliance. Cora Health does hold LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Does Cora Health offer a money-back guarantee?

Cora Health does not currently publish an outcome-based money-back guarantee comparable to Eden’s Weight Loss Warranty. Patients can cancel Cora Health plans according to the published refund policy, but there is no 10%-weight-loss-or-refund product term. For patients who specifically value that type of guarantee, Eden is the more direct path — at the tradeoff of a higher monthly rate.

Which platform has faster shipping and provider approval?

Both platforms typically complete provider approval within 24 hours and ship medications with free expedited delivery. Actual delivery time depends on origin pharmacy, patient address, and carrier performance. Check current delivery estimates through each platform’s patient portal.

Sources & verification

All pricing claims in this comparison are verifiable against each provider's public pricing page. Cora Health publishes its underlying pricing dataset on HuggingFace under a CC-BY-4.0 license for independent verification and reuse. Article last verified against live competitor pricing pages on 2026-05-14.

• Eden (TryEden) public pricing page (verifiable directly at the provider): tryeden.com/pricing
• Cora Health public pricing pages: trycora.io/plans/essential and trycora.io/plans/premium
• FDA — "Compounding and the FDA: Questions and Answers": fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• NEJM — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide: nejm.org/doi/full/10.1056/NEJMoa2032183
• NEJM — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide: nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• LegitScript — Independent verification of Cora Health certification status: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — Hallandale Pharmacy is PCAB-accredited: achc.org/programs/pcab/
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners (full disclosure on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners